Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Preti

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|June 29, 2017
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitorsMauro Marastoni, Claudio Trapella, Alessandra Scotti, et al.
Expert Opinion on Therapeutic Targets|April 16, 2008
The P2X7 receptor as a therapeutic targetRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Bioorganic Chemistry|May 6, 2021
Concise synthesis and biological evaluation of 2-Aryl-3-Anilinobenzo[b]thiophene derivatives as potent apoptosis-inducing agentsRomeo Romagnoli, Delia Preti, Ernest Hamel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 17, 2009
Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cellsStefania Gessi, Eleonora Fogli, Valeria Sacchetto, et al.
Journal of Medicinal Chemistry|September 9, 2020
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH<sub>2</sub>Salvatore Pacifico, Federica Ferrari, Valentina Albanese, et al.
ACS Medicinal Chemistry Letters|July 18, 2019
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome InhibitorsSalvatore Pacifico, Valeria Ferretti, Valentina Albanese, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 24, 2005
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2Pier Giovanni Baraldi, Romeo Romagnoli, Mojgan Aghazadeh Tabrizi, et al.
European Journal of Medicinal Chemistry|May 17, 2003
Recent developments in the field of A2A and A3 adenosine receptor antagonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Andrea Bovero, et al.
Bioorganic & Medicinal Chemistry|December 30, 2011
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonistsPier Giovanni Baraldi, Giulia Saponaro, Mojgan Aghazadeh Tabrizi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 21, 2025
Design and synthesis of 1,4,8-triazaspiro[4.5]decan-2-one derivatives as novel mitochondrial permeability transition pore inhibitorsValentina Albanese, Gaia Pedriali, Martina Fabbri, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Journal of Enzyme Inhibition and Medicinal Chemistry|June 29, 2017
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitorsMauro Marastoni, Claudio Trapella, Alessandra Scotti, et al.
Expert Opinion on Therapeutic Targets|April 16, 2008
The P2X7 receptor as a therapeutic targetRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Bioorganic Chemistry|May 6, 2021
Concise synthesis and biological evaluation of 2-Aryl-3-Anilinobenzo[b]thiophene derivatives as potent apoptosis-inducing agentsRomeo Romagnoli, Delia Preti, Ernest Hamel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 17, 2009
Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cellsStefania Gessi, Eleonora Fogli, Valeria Sacchetto, et al.
Journal of Medicinal Chemistry|September 9, 2020
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH<sub>2</sub>Salvatore Pacifico, Federica Ferrari, Valentina Albanese, et al.
ACS Medicinal Chemistry Letters|July 18, 2019
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome InhibitorsSalvatore Pacifico, Valeria Ferretti, Valentina Albanese, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 24, 2005
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2Pier Giovanni Baraldi, Romeo Romagnoli, Mojgan Aghazadeh Tabrizi, et al.
European Journal of Medicinal Chemistry|May 17, 2003
Recent developments in the field of A2A and A3 adenosine receptor antagonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Andrea Bovero, et al.
Bioorganic & Medicinal Chemistry|December 30, 2011
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonistsPier Giovanni Baraldi, Giulia Saponaro, Mojgan Aghazadeh Tabrizi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 21, 2025
Design and synthesis of 1,4,8-triazaspiro[4.5]decan-2-one derivatives as novel mitochondrial permeability transition pore inhibitorsValentina Albanese, Gaia Pedriali, Martina Fabbri, et al.
Pageof 10